Dynamic Cerebral Autoregulation of Remote Ischemic Conditioning Combined With Intravenous Thrombolysis for Acute Ischemic Stroke
CARIC-IVT
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to determine the impact of remote ischemic conditioning on dynamic cerebral autoregulation in patients with acute ischemic stroke receiving intravenous thrombolysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedNovember 2, 2022
October 1, 2022
3.2 years
November 1, 2021
October 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dynamic cerebral autoregulation of affected sides measured by phase difference(PD) in Degree
A dynamic cerebral auto-regulation parameter derived from transfer function analysis.Continuous cerebral blood flow velocities of bilateral middle cerebral artery will be assessed noninvasively using transcranial Doppler. Spontaneous arterial blood pressure will be simultaneously recorded using a servo-controlled plethysmograph on the left or right middle finger with an appropriate finger cuff size. Transfer function analysis will be used to derive the autoregulatory parameters.
1-2 days
Secondary Outcomes (4)
Dynamic cerebral autoregulation of unaffected sides measured by phase difference(PD) in Degree
1-2 days
Dynamic cerebral autoregulation of affected sides measured by phase difference(PD) in Degree
7-10 days
Dynamic cerebral autoregulation of unaffected sides measured by phase difference(PD) in Degree
7-10 days
Hematology related indicators
before and 24 hours after intravenous thrombolysis
Study Arms (2)
RIC group
ACTIVE COMPARATORRIC+Standard medical treatment Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mmHg. RIC will be conducted twice within 6 to 24 hours from thrombolysis.
control group
PLACEBO COMPARATORSham RIC+Standard medical treatment Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mmHg. RIC will be conducted twice twice within 6 to 24 hours from thrombolysis.
Interventions
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mmHg. All patients underwent dynamic cerebral autoregulation on days 1-2 and 7-10 after onset, and intravenous blood was collected by a nurse and stored in the laboratory 0-6 hours after thrombolysis and 24 hours after thrombolysis.
Sham remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min re-perfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mmHg. All patients underwent dynamic cerebral autoregulation on days 1-2 and 7-10 after onset, and intravenous blood was collected by a nurse and stored in the laboratory 0-6 hours after thrombolysis and 24 hours after thrombolysis.
Eligibility Criteria
You may qualify if:
- Age≥18 years, \< 80 years, regardless of sex;
- Patients with clinically definite diagnosis of acute ischemic stroke and undergo intravenous thrombolysis;
- Baseline NIHSS \>= 5, and \<= 25;
- Baseline GCS ≥8;
- Signed and dated informed consent is obtained
You may not qualify if:
- Patients who undergo endovascular treatment;
- mRS ≥ 2 before the onset of the disease;
- Severe organ dysfunction or failure;
- Those who have a history of atrial fibrillation;
- The patients who have the contraindication of remote ischemic conditioning treatment, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
- Pregnant or lactating women;
- Patients with a life expectancy of less than 3 months or patients unable to complete the study for other reasons;
- He/She is participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to admission;
- Other conditions that the researchers think are not suitable for the group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yi Yanglead
Study Sites (1)
The First Hospital of Jilin University
Changchun, Jilin, 130000, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associated Dean of First Hospital of Jilin University
Study Record Dates
First Submitted
November 1, 2021
First Posted
November 18, 2021
Study Start
September 1, 2018
Primary Completion
November 4, 2021
Study Completion
November 4, 2021
Last Updated
November 2, 2022
Record last verified: 2022-10